Introduction: In Mexico, the prevalence of neurocognitive disorders (NCDs) has increased in parallel with the increase in life expectancy. The E4 allele of the gene that encodes apolipoprotein E (APOE) is the main genetic risk factor for cognitive impairment. Objective: To replicate the association of APOE-E4 allele with neurocognitive impairment in a Mexican population, as well as to implement a genetic risk-detection program with the APOE-E4 allele. Method: A program was structured for the detection of APOE-E4 allele risk in different recruiting centers from the central zone of the Mexican Republic, with three stages: recruitment and selection of candidates for the detection of the risk-allele, genetic risk analysis and delivery of results. Results: In the genetic-association study to replicate the association with neurocognitive disorders by means of multivariate logistic models, the APOE-E4 allele increased the risk for cognitive impairment in the Mexican populations by approximately 6 % (OR: 5.83, p = 0.0025). In addition, 367 genetic risk results were delivered. Conclusions: The present program is the first one to be implemented in Mexico with the purpose to inform on a genetic risk factor for neurocognitive disorders in several centers of the country.
CITATION STYLE
Genis-Mendoza, A. D., Martínez-Magaña, J. J., Bojórquez, C., Téllez-Martínez, J. A., Jiménez-Genchi, J., Roche, A., … Martínez-Hernández, A. G. (2018). Programa de detección del alelo APOE-E4 en adultos mayores mexicanos con deterioro cognitivo. Gaceta Medica de Mexico, 154(5), 555–560. https://doi.org/10.24875/GMM.18003784
Mendeley helps you to discover research relevant for your work.